FDA 510(k) · Masimo
K212876: Carescape SpO2 - Masimo (Masimo Corporation)
Masimo Corporation received FDA 510(k) K212876 for Carescape SpO2 - Masimo, with a decision date of Oct 8, 2021 (substantially equivalent).
Prescription or OTC: Unknown (no FDA document we parsed states it).
FDA facts
| FDA number | K212876 |
|---|---|
| Pathway | 510(k) |
| Applicant | Masimo Corporation |
| Device name | Carescape SpO2 - Masimo |
| Product code | DQA: Oximeter |
| Regulation (21 CFR) | 870.2700 |
| Device class | Class 2 |
| Date received | Sep 9, 2021 |
| Decision date | Oct 8, 2021 |
| Decision | Substantially Equivalent (SESE) |
| 510(k) type | Special |
Source: openFDA device 510(k) data, data through Oct 26, 2026.
Indications for use parsed from FDA documents
We could not extract the indications for this record. Check the FDA record for its summary or statement.
Predicates parsed from FDA documents
FDA numbers found next to the word "predicate" in the summary. The list can include reference devices; check the PDF for which device is the primary predicate.
Later records that cite K212876
- K221953 Masimo CARESCAPE SpO2 Masimo with SpHb (Masimo, Aug 4, 2022, DQA)
ChatPPG interpretation
A 510(k) decision of "substantially equivalent" means FDA found the device as safe and effective as a legally marketed predicate. FDA's word for this is cleared, not approved. The clearance covers the device and indications in this submission; it does not extend to other features or versions of the same product that were not part of it. See FDA cleared vs approved.
Product code DQA is "Oximeter", class 2, 21 CFR 870.2700.
Our labels for filtering: claim SpO2 / pulse oximetry, sensor Finger PPG. These are heuristics, not FDA fields.